Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pearson

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
Internal Medicine Journal|March 1, 2012
Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population registerA K Richardson, G Clarke, C E Sabel, et al.
Histopathology|March 3, 2015
Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patientsZac Gerring, John F Pearson, Helen R Morrin, et al.
Brain : a Journal of Neurology|March 11, 2021
The latitude gradient for multiple sclerosis prevalence is established in the early life courseClive E Sabel, John F Pearson, Deborah F Mason, et al.
The Biochemical Journal|January 22, 2000
Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cellsR M Hill, P K Parmar, L C Coates, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
MS prevalence in New Zealand, an ethnically and latitudinally diverse countryBruce V Taylor, John F Pearson, Glynnis Clarke, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
Scientific Reports|March 31, 2021
Variable expression quantitative trait loci analysis of breast cancer risk variantsGeorge A R Wiggins, Michael A Black, Anita Dunbier, et al.
Plos One|September 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumabBarry D Hock, Liping Goddard, Sean A MacPherson, et al.
Frontiers in Oncology|May 19, 2018
Investigation of Experimental Factors That Underlie <i>BRCA1/2</i> mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic VariantsVanessa L Lattimore, John F Pearson, Margaret J Currie, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Internal Medicine Journal|March 1, 2012
Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population registerA K Richardson, G Clarke, C E Sabel, et al.
Histopathology|March 3, 2015
Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patientsZac Gerring, John F Pearson, Helen R Morrin, et al.
Brain : a Journal of Neurology|March 11, 2021
The latitude gradient for multiple sclerosis prevalence is established in the early life courseClive E Sabel, John F Pearson, Deborah F Mason, et al.
The Biochemical Journal|January 22, 2000
Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cellsR M Hill, P K Parmar, L C Coates, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
MS prevalence in New Zealand, an ethnically and latitudinally diverse countryBruce V Taylor, John F Pearson, Glynnis Clarke, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
Scientific Reports|March 31, 2021
Variable expression quantitative trait loci analysis of breast cancer risk variantsGeorge A R Wiggins, Michael A Black, Anita Dunbier, et al.
Plos One|September 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumabBarry D Hock, Liping Goddard, Sean A MacPherson, et al.
Frontiers in Oncology|May 19, 2018
Investigation of Experimental Factors That Underlie <i>BRCA1/2</i> mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic VariantsVanessa L Lattimore, John F Pearson, Margaret J Currie, et al.
Pageof 25